Selected research
Industry Research
Brain AI-assisted Diagnosis Software Industry Research Report 2026
Market perspective
The global Brain AI-assisted Diagnosis Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Brain AI-assisted Diagnosis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Brain AI-assisted Diagnosis Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Brain AI-assisted Diagnosis Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Brain AI-assisted Diagnosis Software include Deepwise, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX and BioMind, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Brain AI-assisted Diagnosis Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Brain AI-assisted Diagnosis Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Brain AI-assisted Diagnosis Software Market by Company
Deepwise
NeuMiva
G K Healthcare
Sense Time
United Imaging
Infervision
Shukun
FOSUN AITROX
BioMind
NANO-X
Aikenist
VUNO
Brain AI-assisted Diagnosis Software Segment by Type
Cloud-based
On-Primes
Brain AI-assisted Diagnosis Software Segment by Application
Hospital
Clinic
Imaging Center
Brain AI-assisted Diagnosis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain AI-assisted Diagnosis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Brain AI-assisted Diagnosis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-Primes
Applications
- Hospital
- Clinic
- Imaging Center
Companies covered
- Deepwise
- NeuMiva
- G K Healthcare
- Sense Time
- United Imaging
- Infervision
- Shukun
- FOSUN AITROX
- BioMind
- NANO-X
- Aikenist
- VUNO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Brain AI-assisted Diagnosis Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-Primes
- 2.3 Brain AI-assisted Diagnosis Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Imaging Center
- 2.4 Assumptions and Limitations
3 Brain AI-assisted Diagnosis Software Breakdown Data by Type
- 3.1 Global Brain AI-assisted Diagnosis Software Historic Market Size by Type (2021-2026)
- 3.2 Global Brain AI-assisted Diagnosis Software Forecasted Market Size by Type (2027-2032)
4 Brain AI-assisted Diagnosis Software Breakdown Data by Application
- 4.1 Global Brain AI-assisted Diagnosis Software Historic Market Size by Application (2021-2026)
- 4.2 Global Brain AI-assisted Diagnosis Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Brain AI-assisted Diagnosis Software Market Perspective (2021-2032)
- 5.2 Global Brain AI-assisted Diagnosis Software Growth Trends by Region
- 5.2.1 Global Brain AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Brain AI-assisted Diagnosis Software Historic Market Size by Region (2021-2026)
- 5.2.3 Brain AI-assisted Diagnosis Software Forecasted Market Size by Region (2027-2032)
- 5.3 Brain AI-assisted Diagnosis Software Market Dynamics
- 5.3.1 Brain AI-assisted Diagnosis Software Industry Trends
- 5.3.2 Brain AI-assisted Diagnosis Software Market Drivers
- 5.3.3 Brain AI-assisted Diagnosis Software Market Challenges
- 5.3.4 Brain AI-assisted Diagnosis Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Brain AI-assisted Diagnosis Software Players by Revenue
- 6.1.1 Global Top Brain AI-assisted Diagnosis Software Players by Revenue (2021-2026)
- 6.1.2 Global Brain AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Brain AI-assisted Diagnosis Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Brain AI-assisted Diagnosis Software Head Office and Area Served
- 6.4 Global Brain AI-assisted Diagnosis Software Players, Product Type & Application
- 6.5 Global Brain AI-assisted Diagnosis Software Manufacturers Established Date
- 6.6 Global Brain AI-assisted Diagnosis Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 7.2 North America Brain AI-assisted Diagnosis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 7.4 North America Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 8.2 Europe Brain AI-assisted Diagnosis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 8.4 Europe Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 9.2 Asia-Pacific Brain AI-assisted Diagnosis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 10.2 South America Brain AI-assisted Diagnosis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 10.4 South America Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 11.2 Middle East & Africa Brain AI-assisted Diagnosis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Deepwise
- 12.1.1 Deepwise Company Information
- 12.1.2 Deepwise Business Overview
- 12.1.3 Deepwise Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.1.4 Deepwise Brain AI-assisted Diagnosis Software Product Portfolio
- 12.1.5 Deepwise Recent Developments
- 12.2 NeuMiva
- 12.2.1 NeuMiva Company Information
- 12.2.2 NeuMiva Business Overview
- 12.2.3 NeuMiva Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.2.4 NeuMiva Brain AI-assisted Diagnosis Software Product Portfolio
- 12.2.5 NeuMiva Recent Developments
- 12.3 G K Healthcare
- 12.3.1 G K Healthcare Company Information
- 12.3.2 G K Healthcare Business Overview
- 12.3.3 G K Healthcare Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.3.4 G K Healthcare Brain AI-assisted Diagnosis Software Product Portfolio
- 12.3.5 G K Healthcare Recent Developments
- 12.4 Sense Time
- 12.4.1 Sense Time Company Information
- 12.4.2 Sense Time Business Overview
- 12.4.3 Sense Time Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.4.4 Sense Time Brain AI-assisted Diagnosis Software Product Portfolio
- 12.4.5 Sense Time Recent Developments
- 12.5 United Imaging
- 12.5.1 United Imaging Company Information
- 12.5.2 United Imaging Business Overview
- 12.5.3 United Imaging Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.5.4 United Imaging Brain AI-assisted Diagnosis Software Product Portfolio
- 12.5.5 United Imaging Recent Developments
- 12.6 Infervision
- 12.6.1 Infervision Company Information
- 12.6.2 Infervision Business Overview
- 12.6.3 Infervision Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.6.4 Infervision Brain AI-assisted Diagnosis Software Product Portfolio
- 12.6.5 Infervision Recent Developments
- 12.7 Shukun
- 12.7.1 Shukun Company Information
- 12.7.2 Shukun Business Overview
- 12.7.3 Shukun Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.7.4 Shukun Brain AI-assisted Diagnosis Software Product Portfolio
- 12.7.5 Shukun Recent Developments
- 12.8 FOSUN AITROX
- 12.8.1 FOSUN AITROX Company Information
- 12.8.2 FOSUN AITROX Business Overview
- 12.8.3 FOSUN AITROX Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.8.4 FOSUN AITROX Brain AI-assisted Diagnosis Software Product Portfolio
- 12.8.5 FOSUN AITROX Recent Developments
- 12.9 BioMind
- 12.9.1 BioMind Company Information
- 12.9.2 BioMind Business Overview
- 12.9.3 BioMind Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.9.4 BioMind Brain AI-assisted Diagnosis Software Product Portfolio
- 12.9.5 BioMind Recent Developments
- 12.10 NANO-X
- 12.10.1 NANO-X Company Information
- 12.10.2 NANO-X Business Overview
- 12.10.3 NANO-X Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.10.4 NANO-X Brain AI-assisted Diagnosis Software Product Portfolio
- 12.10.5 NANO-X Recent Developments
- 12.11 Aikenist
- 12.11.1 Aikenist Company Information
- 12.11.2 Aikenist Business Overview
- 12.11.3 Aikenist Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.11.4 Aikenist Brain AI-assisted Diagnosis Software Product Portfolio
- 12.11.5 Aikenist Recent Developments
- 12.12 VUNO
- 12.12.1 VUNO Company Information
- 12.12.2 VUNO Business Overview
- 12.12.3 VUNO Revenue in Brain AI-assisted Diagnosis Software Business (2021-2026)
- 12.12.4 VUNO Brain AI-assisted Diagnosis Software Product Portfolio
- 12.12.5 VUNO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst